July 26, 2017 - By Darrin Black
Among 13 analysts covering Dean Foods (NYSE:DF), 4 have Buy rating, 2 Sell and 7 Hold. Therefore 31% are positive. Dean Foods had 25 analyst reports since July 24, 2015 according to SRatingsIntel. The company was initiated on Friday, December 11 by DA Davidson. The company was initiated on Friday, December 2 by KeyBanc Capital Markets. As per Wednesday, December 16, the company rating was initiated by Jefferies. On Thursday, June 29 the stock rating was maintained by Jefferies with Buy. The company was maintained on Tuesday, November 10 by Morgan Stanley. The firm has Buy rating given on Wednesday, November 4 by Deutsche Bank. The stock of Dean Foods Co (NYSE:DF) has Hold rating given on Monday, July 24 by Stifel Nicolaus. On Thursday, January 19 the stock rating was downgraded by Bernstein to Mkt Perform. The firm has Overweight rating by Stephens given on Tuesday, January 12. Jefferies maintained the stock with Buy rating in Friday, May 26 report. See Dean Foods Co (NYSE:DF) latest ratings:
24/07/2017 Broker: Stifel Nicolaus Rating: Hold New Target: $17.0000 Maintain12/07/2017 Broker: Credit Suisse Rating: Sell New Target: $14.0000 Maintain29/06/2017 Broker: Jefferies Rating: Buy New Target: $24.0000 Maintain13/06/2017 Broker: BMO Capital Markets Rating: Hold New Target: $20.0000 Maintain26/05/2017 Broker: Jefferies Rating: Buy New Target: $24.0000 Maintain17/03/2017 Broker: JP Morgan Old Rating: Neutral New Rating: Overweight Upgrade
Analysts expect BioLife Solutions Inc (NASDAQ:BLFS) to report $-0.06 EPS on August, 10.They anticipate $0.05 EPS change or 45.45% from last quarters $-0.11 EPS. After having $-0.07 EPS previously, BioLife Solutions Incs analysts see -14.29% EPS growth. About 41,398 shares traded. BioLife Solutions Inc (NASDAQ:BLFS) has risen 37.27% since July 26, 2016 and is uptrending. It has outperformed by 20.57% the S&P500.
BioLife Solutions, Inc. is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The company has market cap of $44.62 million. The Companys product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. It currently has negative earnings.
Among 2 analysts covering BioLife Solutions (NASDAQ:BLFS), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioLife Solutions had 2 analyst reports since June 14, 2017 according to SRatingsIntel. The company was upgraded on Wednesday, July 5 by Janney Capital. Maxim Group maintained BioLife Solutions Inc (NASDAQ:BLFS) on Wednesday, June 14 with Buy rating.
Investors sentiment increased to 2.33 in 2016 Q4. Its up 0.83, from 1.5 in 2016Q3. It improved, as 3 investors sold BioLife Solutions Inc shares while 0 reduced holdings. 5 funds opened positions while 2 raised stakes. 267,289 shares or 5.47% less from 282,746 shares in 2016Q3 were reported. Price T Rowe Associates Inc Md holds 0% of its portfolio in BioLife Solutions Inc (NASDAQ:BLFS) for 11,800 shares. Vanguard Gru Incorporated reported 95,127 shares stake. Pnc Finance Service Grp Inc owns 10,000 shares for 0% of their portfolio. Ancora Advsrs Limited Liability owns 0% invested in BioLife Solutions Inc (NASDAQ:BLFS) for 2,500 shares. Deutsche Fincl Bank Ag reported 0% stake. Blackrock Fund Advisors has 2,526 shares for 0% of their portfolio. Citadel Advsr Ltd Liability Co invested in 0% or 16,710 shares. Wells Fargo & Mn accumulated 0% or 22 shares. State Bank Of America De reported 0% stake. Geode Capital Llc reported 69,384 shares. Perkins Capital Mgmt Inc, a Minnesota-based fund reported 10,000 shares. Community Commercial Bank Na holds 250 shares. Blackrock Institutional Co Na accumulated 0% or 33,039 shares. Hudock Cap Group Lc has 0% invested in BioLife Solutions Inc (NASDAQ:BLFS). Creative Planning invested in 0% or 143 shares.
Dean Foods Company is a food and beverage company. The company has market cap of $1.42 billion. The Firm processes and distributes fluid milk, and other dairy and dairy case products in the United States. It has a 19.68 P/E ratio. It is engaged in manufacturing, marketing, selling and distributing a range of branded and private label dairy and dairy case products.
Investors sentiment increased to 0.88 in 2016 Q4. Its up 0.05, from 0.83 in 2016Q3. It improved, as 33 investors sold Dean Foods Co shares while 89 reduced holdings. 37 funds opened positions while 70 raised stakes. 96.83 million shares or 7.10% less from 104.23 million shares in 2016Q3 were reported. Monroe National Bank & Trust & Mi stated it has 597 shares or 0% of all its holdings. Fmr Lc owns 1.02M shares or 0% of their US portfolio. Timber Hill Lc holds 0% or 14,977 shares. Envestnet Asset Inc invested in 0% or 5,548 shares. Schwab Charles Incorporated holds 0.03% or 1.14 million shares in its portfolio. Renaissance Technology Ltd reported 1.18 million shares or 0.04% of all its holdings. Gamco Investors Et Al owns 14,173 shares. Macquarie Gp reported 0% in Dean Foods Co (NYSE:DF). Credit Suisse Ag reported 107,575 shares or 0% of all its holdings. Bessemer has 0% invested in Dean Foods Co (NYSE:DF) for 13,180 shares. Prelude Mngmt Llc invested 0.13% in Dean Foods Co (NYSE:DF). Moreover, Robecosam Ag has 0.53% invested in Dean Foods Co (NYSE:DF) for 262,975 shares. Cornerstone Cap Mgmt Hldg Limited Company owns 393,900 shares. State Of Tennessee Treasury Department, a Tennessee-based fund reported 57,000 shares. Qs Invsts Limited Liability Corp has 0.14% invested in Dean Foods Co (NYSE:DF) for 807,000 shares.
Since March 13, 2017, it had 0 insider buys, and 3 insider sales for $174,435 activity. Mailloux J Wayne sold $59,762 worth of stock or 3,033 shares.
By Darrin Black
Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
- I took an international trip with my frozen eggs to learn about the fertility industry - MIT Technology Review - September 16th, 2022
- GM begins US Ultium battery production for Hummer EV in Ohio amidst union pushback - Electrek.co - September 8th, 2022
- On the scent: ETSU researchers exploring treatments for loss of smell - East Tennessee State University - September 8th, 2022
- University of Minnesota researcher seeks to sustain Alzheimer's findings amid image scandal - Star Tribune - August 5th, 2022
- Men Share The Costly Lengths They've Taken To Prevent Balding - HuffPost - July 11th, 2022
- The end of Roe v. Wade affects more than just abortion - Vox.com - July 3rd, 2022
- What Is Radiation Sickness and Are There Drugs to Treat It? - Newsweek - May 15th, 2022
- IMAC Holdings, Inc. Announces Initiation of Third and Final Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for... - March 25th, 2022
- Roslin Tech in multi-million bid to fund sustainable food - HeraldScotland - August 31st, 2021
- What Is DiscGenics, The Company Christopher Duntsch Helped Found, And Where Is It Today? - Oxygen - July 21st, 2021
- Karen Hasty Named Among 2021 Super Women In Business by Memphis Business Journal - UTHSC News - June 6th, 2021
- GM pledges to be carbon neutral by 2040; Dingell applauds efforts - Dearborn Press and Guide - February 16th, 2021
- Former NFL star Eddie George returns to Vero Beach for therapy, this time on shoulder - TCPalm - September 22nd, 2020
- US Performing Hysterectomies On Immigrants? - The Shadow League - September 22nd, 2020
- Sunway University's Collaboration with Harvard Medical School Makes Advances in Potential Cancer Treatment using Gene Therapy - Yahoo Finance - August 26th, 2020
- Non-Profit Offers Free Stem Cell Therapy to Veterans - Pain News Network - March 28th, 2020
- CAR T Cells to Go? Outpatient Therapy Can Be Safe - Medscape - March 1st, 2020
- Breakthrough, Non-Invasive Treatment Called Axol Therapy For Erectile Dysfunction And Enhanced Sexual Performance Now Available At Colorado Urology -... - March 1st, 2020
- Alberta baby Mighty Hudson home after gene therapy: hes cured - Global News - January 24th, 2020
- Year in Review: The Top Science Stories of 2019 - WTTW News - January 5th, 2020
- Early Results Are Positive for Experimental CRISPR Therapies - The Scientist - November 22nd, 2019
- Towards a universal flu vaccine - Scientific American - September 23rd, 2019
- What We Do Stem Cell Institute of Middle Tennessee - March 20th, 2019
- UTHSC | Department of Ophthalmology | Hamilton Eye Institute - March 7th, 2019
- Stem Cell Treatment Nashville TN - Precision Pain Care - January 15th, 2019
- Equine Regenerative Medicine - University of Tennessee system - September 15th, 2018
- Lung Institute | Stem Cell Treatment Tennessee - September 25th, 2017
- Stem Cell Therapy Franklin TN | Stem Cell Treatment - July 7th, 2017
- When C9ORF72 Silences U2, Spliceosomes Can't Find What They're Looking For - Alzforum - July 7th, 2017
- Knoxville TN Stem Cell Treatment | Knoxville Tennessee ... - November 23rd, 2016
- Lung Institute | Stem Cell Treatment Center in TN for Lung ... - November 9th, 2016
- The Stem Cell Transplant Process - Covenant Health - May 12th, 2015
- SpringerPlus | Full text | What makes cancer stem cell ... - April 27th, 2015
- Pros And Cons Of Stem Cell Research - Popular Issues ... - January 29th, 2015
- Chattanoogan.com - Chattanooga's source for breaking local news - November 26th, 2014
- Stem Cell Transplants in Dogs | eHow - eHow | How to ... - November 19th, 2014
- Memphis Tennessee Stem Cell Research | Memphis TN Stem ... - November 11th, 2014
- Human stem cell research - Religious Tolerance - September 27th, 2014
- Stem Cells Macular DegenerationStem Cell Treatments - September 27th, 2014
- Understanding Stem Cell Transplant VICC Momentum - September 27th, 2014
- Tennessee in middle of embryonic stem cell fight | wbir.com - August 26th, 2014
- Stem Cell Transplant Program - Covenant Health - August 23rd, 2014
- Tennessee Stem Cell Therapy | Stem Cell Treatments - August 22nd, 2014